Thomas H. Jensen
Chair of the BoardMr. Thomas H. Jensen is Director of Valion Bio, Inc. from August 27, 2026 and serves as its Chair of the Board since September 17, 2026. He serves as the Chief Executive Officer and Director at Allarity Acquisition Corp. Mr. Jensen is Co-Founder of Allarity Therapeutics, Inc. and serves as its Director since July 7, 2022. He is Chief Executive Officer since December 08, 2023 at Allarity Therapeutics, Inc. and served as its Chief Business Officer since December 2023 until December 8, 2023. He served as Senior Vice President of Investor Relations of Allarity Therapeutics, Inc. since June 29, 2022 until December 2023. He serves as Director at Cardeon AB (publ). He has been Senior Vice President of Information Technology at Allarity Therapeutics A/S (formerly known as Oncology Venture A/S) (formerly known as Oncology Venture Sweden AB) since June 2020 and served as its Chief Technology Officer from 2004 to June 2020. He served as the Senior Vice President of Information Technology at Allarity Therapeutics, Inc. since 2021 until June 29, 2022. Mr. Jensen is pioneering the bridging of: good science, effective laboratory techniques and bioinformatics to advance the biology of cancer. He is pioneering the bridging of: good science, effective laboratory techniques and bioinformatics to advance the biology of cancer. He founded & leads the MPI laboratories in Denmark and in the USA. Along side nurturing global laboratories, he is instrumental in building Medical Prognosis Institute's Investor Relations, securing operational financing and fostering business growth of MPI. Since January 2006, Mr. Jensen had been Chief Technology Officer & Investor Relations of Medical Prognosis Institute A/S since November 26, 2015. Mr. Jensen served as the Chief Technology Officer of Medical Prognosis Institute A/S until November 26th 2015. Mr. Jensen holds a Bachelor of Science degree in Biology from the Technical University of Denmark and conducted further studies in Biology at the University of Copenhagen.
Positions
- Company NameValion Bio, Inc.Stock CodeVBIOPositionChair of the Board
- Company NameAllarity Therapeutics, Inc.Stock CodeALLRPositionFounder, CEO & DirectorColleagues
- GWGerald W. McLaughlinIndependent Chairman of the Board
- JRJeremy R. GraffPresident & Chief Development Officer
- SMSteen Meier KnudsenFounder & Chief Scientific Officer
- JSJeffrey S. ErvinChief Financial Officer
- JLJose L. IglesiasConsultant Chief Medical Officer
- DDDaniel Douglas Von HoffMember of Scientific Advisory Board
- UAUrsula A. MatulonisMember of Scientific Advisory Board
- JAJoyce Ann O'ShaughnessyMember of Scientific Advisory Board
